Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression

Daniel T. Claiborne, Jessica L. Prince, Eileen Scully, Gladys Macharia, Luca Micci, Benton Lawson, Jakub Kopycinski, Martin J. Deymier, Thomas H. Vanderford, Krystelle Nganou-Makamdop, Zachary Ende, Kelsie Brooks, Jianming Tang, Tianwei Yu, Shabir Lakhi, William Kilembe, Guido Silvestri, Daniel Douek, Paul A. Goepfert, Matthew A. Price, Susan A. Allen, Mirko Paiardini, Marcus Altfeld, Jill Gilmour, and Eric Hunter
  1. aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  2. bRagon Institute of MGH, MIT and Harvard, Cambridge, MA 02139;
  3. cHuman Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom;
  4. dFaculty of Medicine, Imperial College, London SW7 2AZ, United Kingdom;
  5. eVaccine Research Center, National Institutes of Health, Bethesda, MD 20817;
  6. fDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294;
  7. gDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322;
  8. hZambia–Emory HIV Research Project, Lusaka, Zambia;
  9. iEpidemiology Unit, International AIDS Vaccine Initiative, San Francisco, CA 94143;
  10. jDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143;
  11. kDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322;
  12. lDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322; and
  13. mVirus Immunology Unit, Heinrich-Pette-Institut, 20251 Hamburg, Germany

See allHide authors and affiliations

PNAS first published February 17, 2015; https://doi.org/10.1073/pnas.1421607112
Daniel T. Claiborne
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica L. Prince
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eileen Scully
bRagon Institute of MGH, MIT and Harvard, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gladys Macharia
cHuman Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Micci
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benton Lawson
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakub Kopycinski
cHuman Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom;
dFaculty of Medicine, Imperial College, London SW7 2AZ, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Deymier
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas H. Vanderford
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krystelle Nganou-Makamdop
eVaccine Research Center, National Institutes of Health, Bethesda, MD 20817;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary Ende
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelsie Brooks
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianming Tang
fDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianwei Yu
gDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shabir Lakhi
hZambia–Emory HIV Research Project, Lusaka, Zambia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Kilembe
hZambia–Emory HIV Research Project, Lusaka, Zambia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido Silvestri
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Douek
eVaccine Research Center, National Institutes of Health, Bethesda, MD 20817;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Goepfert
fDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew A. Price
iEpidemiology Unit, International AIDS Vaccine Initiative, San Francisco, CA 94143;
jDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan A. Allen
hZambia–Emory HIV Research Project, Lusaka, Zambia;
kDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322;
lDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirko Paiardini
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Altfeld
bRagon Institute of MGH, MIT and Harvard, Cambridge, MA 02139;
mVirus Immunology Unit, Heinrich-Pette-Institut, 20251 Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Gilmour
cHuman Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom;
dFaculty of Medicine, Imperial College, London SW7 2AZ, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Hunter
aEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
kDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ehunte4@emory.edu
  1. Edited by Malcolm A. Martin, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved January 21, 2015 (received for review November 11, 2014)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

HIV infection is associated with elevated inflammation and aberrant cellular immune activation. Indeed, the activation status of an HIV-infected individual is often more predictive of disease trajectory than viral load. Here, we highlight the importance of the replicative fitness of the transmitted viral variant in driving an early inflammatory state, characterized by T-cell activation and immune dysfunction. This impact on T-cell homeostasis is independent of protective host immune response genes and viral load. Highly replicating transmitted variants were also significantly more efficient at infecting memory CD4+ T cells, a population important for maintaining the latent viral reservoir. Together, these data provide a mechanism whereby viral replicative fitness acts as a major determinant of disease progression and persistence.

Abstract

HIV-1 infection is characterized by varying degrees of chronic immune activation and disruption of T-cell homeostasis, which impact the rate of disease progression. A deeper understanding of the factors that influence HIV-1–induced immunopathology and subsequent CD4+ T-cell decline is critical to strategies aimed at controlling or eliminating the virus. In an analysis of 127 acutely infected Zambians, we demonstrate a dramatic and early impact of viral replicative capacity (vRC) on HIV-1 immunopathogenesis that is independent of viral load (VL). Individuals infected with high-RC viruses exhibit a distinct inflammatory cytokine profile as well as significantly elevated T-cell activation, proliferation, and CD8+ T-cell exhaustion, during the earliest months of infection. Moreover, the vRC of the transmitted virus is positively correlated with the magnitude of viral burden in naive and central memory CD4+ T-cell populations, raising the possibility that transmitted viral phenotypes may influence the size of the initial latent viral reservoir. Taken together, these findings support an unprecedented role for the replicative fitness of the founder virus, independent of host protective genes and VL, in influencing multiple facets of HIV-1–related immunopathology, and that a greater focus on this parameter could provide novel approaches to clinical interventions.

  • HIV-1
  • Gag
  • replicative capacity
  • immune activation
  • pathogenesis

Footnotes

  • ↵1D.T.C. and J.L.P. contributed equally to this work.

  • ↵2To whom correspondence should be addressed. Email: ehunte4{at}emory.edu.
  • Author contributions: D.T.C., J.L.P., E.S., L.M., B.L., J.K., M.J.D., T.H.V., Z.E., J.T., S.L., W.K., G.S., D.D., P.A.G., M.A.P., S.A.A., M.P., M.A., J.G., and E.H. designed research; D.T.C., J.L.P., E.S., G.M., L.M., B.L., J.K., M.J.D., K.N.-M., Z.E., K.B., and J.T. performed research; E.S., T.Y., S.L., W.K., D.D., S.A.A., and M.A. contributed new reagents/analytic tools; D.T.C., J.L.P., E.S., G.M., L.M., J.K., J.T., T.Y., G.S., M.A.P., M.A., J.G., and E.H. analyzed data; and D.T.C., J.L.P., and E.H. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. KP715723–KP715849).

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1421607112/-/DCSupplemental.

Freely available online through the PNAS open access option.

Next
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Viral replication fitness drives HIV-1 pathology
Daniel T. Claiborne, Jessica L. Prince, Eileen Scully, Gladys Macharia, Luca Micci, Benton Lawson, Jakub Kopycinski, Martin J. Deymier, Thomas H. Vanderford, Krystelle Nganou-Makamdop, Zachary Ende, Kelsie Brooks, Jianming Tang, Tianwei Yu, Shabir Lakhi, William Kilembe, Guido Silvestri, Daniel Douek, Paul A. Goepfert, Matthew A. Price, Susan A. Allen, Mirko Paiardini, Marcus Altfeld, Jill Gilmour, Eric Hunter
Proceedings of the National Academy of Sciences Feb 2015, 201421607; DOI: 10.1073/pnas.1421607112

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Viral replication fitness drives HIV-1 pathology
Daniel T. Claiborne, Jessica L. Prince, Eileen Scully, Gladys Macharia, Luca Micci, Benton Lawson, Jakub Kopycinski, Martin J. Deymier, Thomas H. Vanderford, Krystelle Nganou-Makamdop, Zachary Ende, Kelsie Brooks, Jianming Tang, Tianwei Yu, Shabir Lakhi, William Kilembe, Guido Silvestri, Daniel Douek, Paul A. Goepfert, Matthew A. Price, Susan A. Allen, Mirko Paiardini, Marcus Altfeld, Jill Gilmour, Eric Hunter
Proceedings of the National Academy of Sciences Feb 2015, 201421607; DOI: 10.1073/pnas.1421607112
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

See related content:

  • HIV-1 fitness as a disease determinant
    - Mar 16, 2015
Proceedings of the National Academy of Sciences: 118 (14)
Current Issue

Submit

Sign up for Article Alerts

Jump to section

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Smoke emanates from Japan’s Fukushima nuclear power plant a few days after tsunami damage
Core Concept: Muography offers a new way to see inside a multitude of objects
Muons penetrate much further than X-rays, they do essentially zero damage, and they are provided for free by the cosmos.
Image credit: Science Source/Digital Globe.
Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Venus flytrap captures a fly.
Journal Club: Venus flytrap mechanism could shed light on how plants sense touch
One protein seems to play a key role in touch sensitivity for flytraps and other meat-eating plants.
Image credit: Shutterstock/Kuttelvaserova Stuchelova.
Illustration of groups of people chatting
Exploring the length of human conversations
Adam Mastroianni and Daniel Gilbert explore why conversations almost never end when people want them to.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490